After the progress made during the genomics era, bioinformatics was tasked with supporting the fl ow of information generated by nanobiotechnology efforts. This challenge requires adapting classical bioinformatic and computational chemistry tools to store, standardize, analyze, and visualize nanobiotechnological information. Thus, old and new bioinformatic and computational chemistry tools have been merged into a new sub-discipline: nanoinformatics. This review takes a second look at the development of this new and exciting area as seen from the perspective of the evolution of nanobiotechnology applied to the life sciences. The knowledge obtained at the nano-scale level implies answers to new questions and the development of new concepts in different fi elds. The rapid convergence of technologies around nanobiotechnologies has spun off collaborative networks and web platforms created for sharing and discussing the knowledge generated in nanobiotechnology. The implementation of new database schemes suitable for storage, processing and integrating physical, chemical, and biological properties of nanoparticles will be a key element in achieving the promises in this convergent fi eld. In this work, we will review some applications of nanobiotechnology to life sciences in generating new requirements for diverse scientifi c fi elds, such as bioinformatics and computational chemistry.
INTRODUCTION
Richard Feynman introduced nanotechnology as a concept in 1979 during a conference at the California Institute of Technology. In that conference, Feynman gave an anticipatory talk, "There is Plenty of Room at the Bottom," suggesting that individual atoms and molecules could be manipulated, allowing the controlled production of materials at the nanometer scale with promising technical, industrial, and biological applications (Drexler, 1992) . This conference and its derived material would later be considered the theoretical starting point for the development of nanotechnology. Since then, nanotechnology has created a revolution, not only in the fi elds of physics, chemistry, materials science, engineering, environmental sensing, manufacturing, and quantum computing, but also with across-the-board applications in clinical research and biotechnology. Consequently, initiatives have created an international focus on new synthesis strategies, structures, phenomena, and properties associated with dimensional length scales residing between 1 and 100 nm (Tomalia, 2005) .
Although many strategies have been applied to advance nanotechnology, a new approach, based on the organization, interpretation, and prediction of the structure and physical-chemical properties of nanoparticles and nanomaterials, is gaining momentum. The applications of computer technologies, information science, and molecular simulations have been gaining terrain as key methodologies to nanobiotechnology and nanoinformatics research; these methodologies are suitable to produce qualitative concepts, insights, and design suggestions. While bioinformatics is frequently related to the use of computational tools to analyze DNA and protein sequence data, nanoinformatics is applied in the context of characterizing particles and materials with application in nano-and biotechnology, by modeling and simulating them, in many instances at the atomic level, using computational chemistry strategies.
Introducing foreign bodies into the complex machinery of the human body is, however, a great challenge. Computeraided methods are the natural option to speed up the development of innovation in life sciences. However, new procedures for annotation and simulation of nanoparticle properties should be developed and analyzed to determine the limitations of computational methods applied in this fi eld.
The introduction of new information techniques to nanobiotechnology problems may accelerate the development of highly specific biomedical treatments, increase their effi ciency, and minimize their secondary effects, among other applications. In this contex the concept of nanomedicine emerges, which has advanced rapidly in the last fi ve years. A simple analysis of the number of web links related to the term "nanomedicine" shows exponential growth.
The first nanomaterials for biomedical sciences were designed in 1985, and since 2004, the term "nanomedicine" has been in widespread use. So far, the emergence of modern nano-biomedical sciences has been dominated by applications to biomedical problems, such as technological products from breakthrough synthetic methods in lipid (liposomes), polymer (dendrimers), and colloid chemistry (metal colloids), and the discovery of entirely new chemical processes like fullerene and quantum-dot synthesis. All these new molecular systems have potential applications in diagnostics and therapy.
The lack of a common language as a mechanism for sharing knowledge is a huge impediment, especially in new disciplines. This emphasizes the need for governmental and other databases to organize and/or develop joint dictionaries and ontologies so that data can be collected more meaningfully. On the other hand, the nature and the amount of new data from nanotechnology efforts require GRID tools for their rapid analysis. Multi-scale datasets (from eM histopathology to molecular descriptors) are massive (15 Tb with current technologies) and analyses using combined data from multiple sources can only be achieved in a distributed environment, like GRID systems, which is the only realistic way to operate with this huge amount of information that in the near future can be combined with genomic information.
In what follows, we will analyze the state of the art in nanobiotechnology informatics by dividing the problem into four discrete areas, including social aspects (convergence of nanotechnology and medical sciences around nanoinformatic problems); new extension to classical bioinformatics methods; new modelling challenges, and the budding emergence of collaboratory environments, the later being a characteristic element of nearly every new nanoinformatics initiative.
CONVERGING TOWARD NANOBIOTECHNOLOGY AND NANOMEDICINE
This section will describe some of the tools and technologies that will accelerate the evolution of nanobiotechnology, such as new databases and storage systems adapted to process information generated in nanomedicine, critical for the design, modeling, simulation and visualization of nanosystems applied to the life sciences. As suggested before, the new data and knowledge obtained at the nano-scale level imply the development of new ontologies (nano-ontologies), to achieve a conceptual consensus of all information, terminology, and methodologies used in this fi eld. Today, nanomedicine has branched out into hundreds of directions; each subdiscipline is developing the ability to manipulate structure and devices at the molecular scale, which can bring enormous and immediate benefi ts to medicine (ETP Nanomedicine, October 22, 2009; Freitas, 2005) . These applications focus on treatment, monitoring, and diagnostics in new methods for drug administration and control of biological systems (ETP Nanomedicine, October 22, 2009; Farokhzad and Langer, 2006; Thierry, 2009) .
Economic and other resources have been directed at developing new technologies in nanomedicine to reduce the mortality and morbidity rates, the prevalence of disease and the general social burden (ETP Nanomedicine, October 22, 2009). The growing interest in nanomedicine and the exponential generation of data at the nano-scale level have enabled interdisciplinary groups to work together to create new nanoparticles with biomedical application. These data require an exhaustive analysis of their physical-chemical properties and an extensive structural characterization (ETP Nanomedicine, October 22, 2009; Farokhzad and Langer, 2006) , which involves an intensive use of computational resources.
For these reasons, nanoinformatics emerged to satisfy the need to develop computational tools able to support the analysis of information generated each day in nanomedicine (García-Remesal et al., 2007; Gonzalez-Nilo Danilo and Cachau, 2008; Iglesia et al., 2009) . Nanoinformatics was supported in a fi rst stage by the U.S. National Science Foundation (de la Calle et al., 2009 ) and other international initiatives like the Action-Grid project. Another useful research initiative in nanomedicine is the BioInformatics Resource Inventory (BIRI). BIRI is an approach for automatically discovering and indexing available public bioinformatics resources, using information extracted from scientifi c literature. This tool is based on a domain-independent approach (De la Calle et al., 2008; García-Remesal et al., 2007) , that can be used to create inventories targeting different scientifi c fi elds. For now, this approach is currently being applied in the European Commission-funded Action Grid project. T h u s , n a n o m e d i c i n e i s a n e w f i e l d g a t h e r i n g the applications of nanotechnologies to healthcare (ETP Nanomedicine, October 22, 2009 (Sommerfeld et al., 2009; Talbi and Zomaya, 2007) .
At the same time, a bioinformatics (databases/-omics) and computational chemistry approach (design/modeling/ simulation) can be used to evaluate nanosystems for nanomedicine in therapy and diagnostics. Initially, this area was unexploited due to the complex nature of biological and pharmacological systems, and also due to the expertise and interdisciplinary efforts required to formulate computational models for complex phenomena at the nano-scale level (Tentoni, 2003) .
The application of nanosystems in personalized medicine, such as drug delivery systems and nanosystems for diagnostics and therapy, requires developing computational tools and methodologies for its modeling and simulation and the implementation of strategies to interpret the information generated after the interaction of specifi c organisms with these nanosystems.
Recent studies (Milanesi et al., 2009 ) have established a scheme where all the aforementioned components converge around the study of a complex biomedical system (see Figure 1 ). Several nanotechnological research lines emerge in health that can provide new ideas and concepts for solving pathological mechanisms and lead to novel therapeutic orientations.
NEW CHALLENGES FOR BIOINFORMATICS AND COMPUTATIONAL CHEMISTRY IN NANOBIOTECHNOLOGY
A computational approach is important in the early stages of project development at the nano-scale level. It can be used as a predictive technique in designing nano-transport systems for specifi c drugs or molecular devices (Tentoni, 2003; Thierry, 2009) . Large molecular systems are used today as vehicles or transportation platforms because they can be modifi ed with various chemical groups that confer solubility, affi nity, and selectivity for specifi c sites of a cell (Kang et al., 2009; Tentoni, 2003; Thierry, 2009) . In recent years, computational molecular design has become an increasingly important fi eld in researching new nanomaterials (Rickman and LeSar, 2003) ; this results from increased calculational capacity and the consolidation of a number of methodologies of computational chemistry (Gao, 2001) .
Computational chemistry is a powerful tool to design, model, simulate, and visualize nanomaterials (Gao, 2001 ) and nanoparticles, such as dendrimers (Belting and Wittrup, 2009; Diekmann and Lindhorst, 2002; Newkome and Shreiner, 2007; Selim and Lee, 2009) Computer-assisted nanomolecule design has emerged from recent advances in computational chemistry and nanotechnology and is considered well suited for assisting the experimental community in the design of new nanostructures (Bewick et al., 2009 ). The major advantage of computational nano-design is that it provides a relatively inexpensive and rapid way to explore many structural designs, including the study of stability and prediction of properties (Shapiro et al., 2008) .
The application of modeling methods and nano-scale simulation to nano-design demands new methods or the adaptation of the techniques used in computational chemistry, such as classical molecular dynamics simulations (Fermeglia and Pricl, 2009; Gates et al., 2005) , molecular mechanics (Shapiro et al., 2008) and quantum mechanics (Gates and Hinkley, 2004; Shapiro et al., 2008) . Besides the use of these computational methods at the atomic level, it is necessary to implement new approaches in the use of quantitative structure-activity relationship (QSAR) studies in this fi eld (Shapiro et al., 2008) .
Computational chemistry using molecular dynamics (MD) in nanostructures requires a good characterization of physical and chemical properties (Shapiro et al., 2008 ) to obtain accurate simulation results about the structural and dynamic properties of nanosystems at the atomic level (Gates et al., 2005) . The Collaboratory for Structural Nanobiology (CNS) (http:// nanobiology.utalca.cl) is the fi rst initiative in the world that includes a database of nanoparticle structures. The fi rst stage of this initiative includes more than 120 models of dendrimers built using advanced molecular simulation techniques. CNS is an initiative of SAIC-NCI, USA, in collaboration with CBSMUTalca from Chile.
Computational chemistry using molecular mechanics (MM) can be used to determine the optimized structure of nanoparticles or nanomaterials (lowest energy conformation). This is based on a model of molecules where spheres describe atoms and springs represent the bonds among them (Gates and Hinkley, 2004) . The total energy of the molecule is calculated as the sum of energies implemented in a particular force field (energies of stretching, angles, torsion, VdW interactions, electrostatic interactions, and hydrogen bonds) (http://www.charmm.org/html/documentation/c34b1/ energy.html). Thus, modeling at the nano-scale requires force fi elds that are suffi ciently accurate for both the inorganic and organic components of the nanostructures. These features are extremely important for determining the 3D structural characteristics of nanostructures.
Computational chemistry also uses quantum mechanics (QM) such as semi-empirical, ab initio, and density functional theory (DFT) to predict the molecular structure at the electronic level of nanomaterials and to compute different molecular descriptors that depend on the electronic configuration of the system (Shapiro et al., 2008) . These methods are limited not only by the number of degrees of freedom, but also by the time scale that requires this kind of calculations (http://www.charmm.org/html/documentation/ c34b1/energy.html; Shapiro et al., 2008) . For this reason, the application of QM methods to nanoscale simulation for nanodesign demands new methods or an adaptation of the techniques traditionally used.
Several studies have been carried out using a cycle based on theoretical and experimental studies, with the aim of achieving a better understanding of systems at the nano-scale. For example, Haddish-Berhane et al. (Haddish-Berhane et al., 2007) have studied a multiscale framework to integrate current computational approaches at different scales for drug delivery problems based on nanoparticles (Figure 2 ). It is expected that about 30% of pharmaceutical expenditure will be based on computer simulation, through an integrated effort between experimental and theoretical groups.
Theoretical models for the design of nanoparticles are diverse and use different approaches developed over the last 40 years in computational chemistry. For example, Deduzzi et al. et al., 2009b) , using modeling techniques, have developed a theoretical study about size, shape, and surface of nanoparticles. Such features seem to play an important role when used as carriers and sensor systems in the intravascular journey.
Another example is the study by Pillay et al. (Sibeko et al., 2009 ) that employed advanced computational tools to design a drug delivery system based on a biopolymeric membrane. Specifi cally, the group studied the infl uence of triethanolamine on the release properties of methotrexate from a composite biopolymeric membrane. Properties such as drug entrapment efficiency and the mechanisms of drug delivery have an important impact on the design of these kinds of systems. These properties require in-depth study and characterization at the molecular level. Thus, the design of new nano devices requires advanced computational tools to accelerate understanding of the mechanics of drug delivery.
Therefore, the need for accuracy and speed in the design of nanostructures requires the development of new computational chemistry methodologies or adaptation of existing ones to generate workfl ows and protocols to design suitable nanostructures. , such as CHARMM and AMBER, include both bonded and non-bonded interactions between all the represented atoms, plus expressions to model the effect of Van der Waals and Coulomb potentials, incorporating the system's projected long-range effects induced by mass and charge (Daggett, 2001; MacKerell et al., 2000) . Despite the validity of the mathematical expressions that compose the available force fi elds, parameterization constants are included in all the bonded and non-bonded terms. These constants are fi ne-tuned, using either pure quantum mechanic calculations (ab initio) or empirically based approaches (Ponder and Case, 2003) . When compared to wet-lab experiments, molecular simulation results have proven to be as accurate as typical experimental methods like microcalorimetry (Patra and Karttunen, 2004; Ponder and Case, 2003; Price and Brooks, 2002) . Thus, molecular simulations based on force fi elds have become a popular methodology to explore the behaviour of biomolecules at all the micro-, meso-, and nano-scales.
As noted before, molecular simulation techniques depend on the structure of the biomolecular system to be modelled. Consequently, there is much attention to developing databases to contain molecular structure data. Since the primordial research efforts dedicated to producing crystallographic structures of biomolecules in the 1970s, public databases, such as the Protein Data Bank (PDB; www.pdb.org, Rutgers University, the State University of New Jersey, and the University of California, San Diego, CA, USA), have grown to comprise more than 62.000 biomolecular 3D structures (nearly 35,000 unique structures). However, the growth of unique folds at PDB and the results of joint international efforts, such as the Structural Genomics Project (Lundstrom, 2007; McGuffi n and Jones, 2002; Sali et al., 2007) , demonstrate that we know only a portion of the different architectures and macromolecular arrangements in the human body. Moreover, the complexity of the intracellular environment complicates crystallization for many proteins. As a consequence, membrane-integral proteins such as channels and other transporters are usually underrepresented in databases like PDB.
B a s e d o n a s e m i n a l w o r k f ro m t h e 1 9 8 0 s t h a t demonstrated that the structure is more conserved than the sequence , new methods to produce molecular models based on reference structures have been developed (Sali and Blundell, 1993; Sali et al., 1995; Sanchez and Sali, 2000) . These methods, commonly known as comparative modelling techniques, are suitable under some restrictions, to produce models able to be used as sources for protein engineering (Colombres et al., 2008; Eyzaguirre et al., 2004) and computer-based drug design Lizama et al., 2009; Vasquez et al., 2007) , to explore structure-function relationships (Artigas et al., 2008b; Barria et al., 2009; Carvajal et al., 2003; Ehrenfeld et al., 2008; Stange et al., 2008; Strobel et al., 2005; Tischler et al., 2005) , and signal-transducing mechanisms (Gonzalez et al., 2008; Inestrosa et al., 2005; Strobel et al., 2004) , among a variety of applications.
Extensive efforts have been made at the experimental level to characterize the fundamental physicochemical properties of nanoparticles with potential applications in biomedical sciences. However, all these efforts have faced the limits of current experimental techniques, because the nanoscale has proven to be too small for light microscopy, while too polydisperse for x-ray crystallography, too heterogeneous for NMR, and too "wet" for electron microscopy (Lu et al., 2006) . Under these circumstances, molecular modelling and simulation techniques have arisen as key methodologies to nanobiotechnology research, suitable to produce qualitative concepts, insights, and design suggestions. Thus, quantum mechanics, molecular modelling and molecular simulation techniques provide representations of nanosystems at the atomic level with electronic resolution, offering a suitable framework for the characterization of diverse physical-chemical properties of nanosystems. Advancing in these efforts, the reports of several molecular dynamics (MD) simulations of nanoparticles and other nanosystems demonstrated the suitability of these computer-based techniques to explore and understand basic properties of nanoparticles and nanomaterials (Cieplak and Thompson, 2008; Khurana et al., 2006; Martin et al., 2008; Zimmerli and Koumoutsakos, 2008) . Moreover, these tools provide a unique source of information not only to model basic nanoparticle properties, but also to gain insight into interactions with biological systems. The application of computer-intensive methods like hybrid quantum mechanics and molecular dynamic (QM/MM) simulations, enriched with proper algorithms to effi ciently sample the vast conformational space, will permit characterizing a wide variety of nanoparticle properties, obtaining insights into the biological phenomena that command nanoparticle recognition by physiological systems (Arayne et al., 2007; Archakov and Ivanov, 2007; Bianco, 2004) .
DEVELOPMENT OF COLLABORATIVE NETWORK PLATFORMS FOR NANOBIOTECHNOLOGY

5-a. Design web portals
To facilitate data-sharing (recent literature, tutorials, papers, links, and access points to nanomedical databases; jobs, and news, updated daily) in the research community to expedite and validate the use of nanoparticles, nanomaterials, and nanosystems in nanomedicine (ETP Nanomedicine, October 22, 2009; Gordon and Sagman, 2003) . Nanowerk Nanotechology Portal (http://www.nanowerk.com), NanoLink (http:// www.nano-link.net), and CaNanoLab (http://cananolab. abcc.ncifcrf.gov) are clear examples of portals dedicated to promoting the information generated in nanomedicine and nanotechnology. The fi rst is a portal with a great variety of links to and directories about nano research, daily news, and nanotechnology feature articles, reports, an events calendar, and a nanomaterial database focused on nanomedicine (NanoLink is a web portal). The second portal links to sites that focus on life quality through technological innovation (LINK=Life quality through Innovation by a Network of Knowledge). NanoLINK will be a consolidated network of networks focused on nanotechnology (nanoLINKnet) (Nanowerk Nanotechnology Portal). CaNanoLab is also a web portal focused on dissemination of nanobiological information across the scientifi c community (The Cancer Nanotechnology Laboratory (caNanoLab) Portal).
5-b. Implementation and maintenance of forums
Forums provide a platform of interactive communication to discuss the new possibilities offered by nanotechnology in medicine and thus promote technology and information transfer among different areas of science, health, the pharmaceutical industry, and education, among others, sustained through nanoinformatics. Such forums include the Nanoforum (http://www.nanoforum.org/), NanoNewsBoard Forum (http://www.amtexpo.com/nano/), and the Institute of Nanotechnology Forum (http://www.nano.org.uk/forum/ index.php). The Nanoforum was developed by the European Commission through FP5 to disseminate the advances of different areas of nanotechnology, including, of course, the development of nanomedicine, its current outlook, and its projections based on the successful discussion of nano-scale research (Funding and Support for International Nanotechnology Collaborations Nanoforum report, December 2005). The second forum, NanoNewsBoard, is a nanotechnology forum sponsored by Access Multimedia Technology, Inc. (USA) (NanoNewsBoard); and the third forum was implemented by the Institute of Nanotechnology (IoN-UK) (Institute of Nanotechnology Forum). Both forums contain nanotechnology news, including nanomedicine (ETP Nanomedicine, October 22, 2009). These forums update users on the latest advances in applying nanotechnology to medicine. The Collaboratory for Structural Nanobiology (CSN) (http:// csn.ncifcrf.gov/csn), the nanoHUB (http://nanohub.org/), and NanoMedNet (http://www.nano.org.uk/nanomednet/). The first is a nanobioinformatic web service dedicated to collecting, curating, and correlating structural, physicalchemistry, biological, and biomedical data (The Collaboratory for Structural Nanobiology). The second is a web platform for research, education, and collaboration in nanotechnology (Nanohub Forum) . The third, NanoMedNet, is a collaboration web platform that promotes information about various aspects of the emerging fi eld of nanomedicine and develops services, tools, and education and training for medical professionals related to nanomedicine (NanoMedNet).
5-c. Development of thematic networks and collaboration
5-d. Creation of storage systems and data exchange
The major increase of data and information generated through measurement or calculation of physical and (Tentoni, 2003) , tools for visual analysis of nanoimages (Mauger et al., 2007) and data-mining of biomedical data (Zweigenbaum et al., 2007) , require the creation and implementation of systems and tools for sharing and storing this information. The creation of databases or repositories (Database of Nanoparticles; Mauger et al., 2007; Sommerfeld et al., 2009) to allow the exchange of information about the 3-D structural and data of the physical and chemicals properties of nanoparticles with biomedical applications, such as dendrimers, nanotubes and metal particles, and quantum dots, among others, is critical for the multidisciplinary development of nanomedicine.
Biomedical data are being generated at different levels. Specifically, the atomic level (nanomedicine) has seen an explosive increase (ETP Nanomedicine, October 22, 2009) . This large fl ow of information requires secure and easily available storage systems. The current information storage systems, called data warehouses, can be expanded to accommodate the information generated in nanomedicine. Thus, the data warehouses (Sommerfeld et al., 2009; Staggers et al., 2008; Talbi and Zomaya, 2007) can be optimized through nanoinformatic tools and the technologies of information and communication (TICs) as storage systems for nano-scale systems useful in medicine.
Several projects in this area have been developed. This is the case with the structural database CSN (http://nanobiology. utalca.cl), The CaNanoDB (https://gforge.nci.nih.gov/ projects/canano/) and The ICON EHS Database (http://icon. rice.edu/research.cfm). The fi rst is a structural database of various nanoparticles with possible nanomedical applications. This site offers downloadable nanopdb fi les, related research data, and resources for visualization of different nanoparticles, such as dendrimers, nanotubes and metallic particles (CSN). The second, caNano Database (CaNanoLab) , includes all available technologies and a toolbox for modeling targeted drug delivery and diagnostics using nanoparticles as transport platforms (The cancer Nanotechnology Laboratory [caNanoLab] Portal). The third project is a database that contains summaries (abstracts) and citations for research papers related to the health and safety implications of nanoscale materials (The ICON EHS Database).
CONCLUSION
Bioinformatics and molecular simulations have evolved around biotechnology related problems helping the researcher explore complex problems from genome analysis to protein structure. Now, the accelerated convergence of biotechnology and nanotechnology poses new challenges to the information and modeling fields. The newer scientific fi elds of nanobiotechnology and nanomedicine present a great opportunity for the scientifi c community to merge many of the concepts and tools developed during the past few decades in computational chemistry and computational biology. The tools of these fi elds, such as databases, storage, ontologies, and annotation (bioinformatics), should be merged with design, modeling, simulation, and visualization (computational chemistry) of nanosystems, to generate a new sub-discipline: nanoinformatics.
The applications of nanotechnology in medicine and biotechnology require advanced approaches to manipulate nanoparticles data at the molecular level (nano-scale); these approaches are complex and are frequently handled through the implementation of collaborative networks and the creation of web platforms for sharing and discussing the knowledge generated.
As indicated in the previous sections, the impact of molecular modelling and simulations in nanobiotechnology has been steadily increasing during the last decade. Molecular modelling and simulations offer a unique way to explore interactions at different scales that range from thousands of atoms, to even millions of them. Through these simulations, fundamental physicochemical properties of nanoparticle and other nanoscale systems can be studied. The ever-increasing capacity of modern computer platforms, together with a systematic price reduction, will allow the embedding of molecular simulations in different nanotechnology sub-fi elds. The identifi cation of the intermediate complexity modules that defi ne and control the properties of complex nanodevices will be a main objective of many of these computer simulations given the importance of modular approaches in the rational design of engineered nanomaterials.
The implementation of new database schemes suitable to store and to process data generated in nanobiotechnologyconnecting physical, chemical, and biological properties of the nanoparticle-will be a key element in deriving the knowledge needed to develop this quality of information.
Thus we can envision the emergence of nanoinformatics as a new discipline comprising the vast set of computer-related tools to model, store, and analyze nanotechnology highly diverse data with an increasing role of atomic level simulation tools in the nanodesign cycle.
The implementation of these new techniques may accelerate the development of highly specific biomedical treatments through design, increasing nanobiomaterials efficacy, specificity and bioavailability, while minimizing secondary effects, opening the door to a new era of personalized medicine with materials designed from the bottom up. (Drexler, 1992 , citing Feynman, 1959 .
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